Literature DB >> 16755681

WHO discussion on the improvement of the quality control of BCG vaccines. Pasteur Institute, Paris, France, 7 June 2005.

I Knezevic1, M J Corbel.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16755681     DOI： 10.1016/j.vaccine.2006.03.014

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  4 in total

Review 1.  Latent tuberculosis: what the host "sees"?

Authors:  Hannah P Gideon; JoAnne L Flynn
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

2.  Lipid phenotype of two distinct subpopulations of Mycobacterium bovis Bacillus Calmette-Guerin Tokyo 172 substrain.

Authors:  Takashi Naka; Shinji Maeda; Mamiko Niki; Naoya Ohara; Saburo Yamamoto; Ikuya Yano; Jun-Ichi Maeyama; Hisashi Ogura; Kazuo Kobayashi; Nagatoshi Fujiwara
Journal:  J Biol Chem       Date:  2011-10-26       Impact factor: 5.157

Review 3.  Quality control and safety assessment of BCG vaccines in the post-genomic era.

Authors:  Tzvetelina Stefanova
Journal:  Biotechnol Biotechnol Equip       Date:  2014-07-10       Impact factor: 1.632

4.  The establishment of sub-strain specific WHO Reference Reagents for BCG vaccine.

Authors:  Belinda Dagg; Jason Hockley; Peter Rigsby; Mei M Ho
Journal:  Vaccine       Date:  2014-10-11       Impact factor: 3.641
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.